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The genetic regulation of the murine immune response to a variety of anti- 
gens has been found to  map  in  the I  region within H-2,  the  mouse major 
histocompatibility complex (1, 2).  It is now clear that more than one immune 
response gene (Ir gene) in the I region may be involved in the regulation of the 
immune response to some of these antigens (3, 4). In addition to the complexity 
ofIr gene interaction, there is no definite evidence indicating which cell type(s) 
express Ir gene functions. It is not at all clear whether some or all Ir genes are 
expressed in bone marrow-derived antibody-forming cell precursors (B  cells) 
and/or in thymus-dependent  lymphocytes (T cells) required for carrier recogni- 
tion and helper cell function in the humoral immune response (1, 5-7). Further, 
it would appear that I-subregion identity between B and T cells may be required 
for effective B-cell-T-cell collaboration (8-10) and/or induction to IgG antibody 
synthesis (11), even for antigens that are apparently not under Ir gene control. 
The I  region also determines the structure of a  series of polymorphic cell 
surface molecules designated Ia, forI-region-associated  antigens (2). Ia antigens 
have been demonstrated primarily on lymphocytes, macrophages, sperm, epi- 
dermal cells,  and late gestation fetal liver cells  (12-14). These antigens are 
easily detected on B cells (12, 14), and the rate of development of Ia-positive cells 
in the spleen during neonatal ontogeny is closely correlated with that of immu- 
noglobulin (Ig)-bearing cells (15, 16). Several laboratories have been able to 
detect Ia  antigens on thymocytes and T-cell  subpopulations as well  (17-19), 
although  with  more  difficulty.  Since/-region gene products  are  the  major 
stimulatory determinants for the generation of mixed lymphocyte reactions, T 
cells presumably recognize B cell (and T cell) Ia antigens (20-22). In light of the 
evidence that/-region homologies facilitate cellular interactions, it has been 
speculated that Ia antigens may act as regulatory molecules in the immune 
response,  or as recognition sites or signals for B-cell-T-cell interaction and 
induction (23-25). Ia determinants may also be associated with enhancing (6, 26, 
27) and suppressing (28) factors putatively elaborated by activated T cells. If  I- 
region gene products are expressed on T  cells and these products recognize 
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antigen, then these determinants may function as antigen recognition units 
(29). 
The studies reported in this communication were initiated (a)  to determine 
whether Ia antigens are expressed on all hapten-specific primary and secondary 
B cells; (b) to determine whether the expression of Ia antigens can be used as a 
marker  to  delineate  primary  B-cell  subpopulations;  and  (c)  to  determine 
whether Ia antigens play a role in the antigenic stimulation of B cells, particu- 
larly with regard to T-cell-B-cell interactions.  Spleen cells from nonimmune 
(primary) and previously immunized (secondary) donor mice were negatively 
selected by pretreatment with an anti-Ia antiserum and complement and then 
analyzed for precursor cell activity by an in vitro splenic focus technique for B- 
cell cloning (30) which maximizes carrier help for B-cell stimulation. The results 
of these experiments indicate that (a)  the majority of primary precursor cells 
and almost every secondary precursor cell is Ia positive; (b) a finite subpopula- 
tion of Ia-"negative" primary precursor cells exists in the spleens of nonimmune 
mice;  and  (c)  the  Ia-negative  primary  B-cell  subpopulation contains  those 
precursor cells which give rise solely to IgM antibody production, whereas the 
Ia-positive B-cell subpopulation contains precursor cells capable of giving rise to 
IgG antibody production, or both IgG as well as IgM antibody, under appropri- 
ate stimulatory conditions. It has been demonstrated recently that a significant 
proportion of primary precursor cells can be stimulated in the carrier-primed 
allogeneic environment, but that only IgM antibody production is elicited. This 
effect has been mapped to the I-A-I-B subregions (11). Since the studies reported 
here demonstrate that the majority of  primary precursor cells are Ia positive and 
have the capacity to give rise to IgG antibody production upon syngeneic T-cell 
interaction,  these  results  suggest  that  Ia  antigens may play  a  role  in,  or 
correlate with, the ability of the B  cell to switch from IgM to IgG antibody 
production. The results also suggest that Ia recognitive interactions between T 
cells and B cells are not required for stimulation to IgM antibody production, 
even when B-cell stimulation is T-cell dependent. 
Materials and Methods 
Animals and Immunization.  Breeding pairs of the congenic line BALB.K (H-2 k) were provided 
by Dr. Frank Lilly. This congenic line was maintained by brother-sister mating. Mice were carrier 
primed with 0.1  mg of Limulus polyphemus  hemocyanin  (Hyp  in complete Freund's adjuvant 
(CFA) 2-3  mo before use as recipients for cell transfer.  Donor spleen cells were obtained either 
from nonimmune mice (primary precursor cell analysis) or from mice immunized 2-4 mo previ- 
ously with 0.1 mg of 2,4-dinitrophenylated Hy (DNP-Hy; i0 mol of DNP per 100,000 g of Hy) (31) in 
CFA (secondary precursor cell  analysis). 
Irradiation.  Carrier-primed (Hy) recipient  mice were lethally  irradiated  6 h before  cell  trans- 
fer  with 1,100-1,300  R from a Phillips  X-ray generator, at 15  mA and 250  kV, with  a corrected  0.25 
mm  Cu/1.0 mm  Al filter,  half  value layer (HVL)-I.3 mm  Cu, delivering  62  R/rain,  at  a distance of 
64 cm to  midmouse. 
Antiserum and Complement.  A.TH anti-A.TL antiserum (anti-lak),  A.TL anti-A.TH antise- 
rum (anti-la~),  and (A.TH × B10.HTT)F~ anti-A.TL antiserum (anti.IA  k,  IB  k)  were produced in 
this  laboratory by methods described previously (12,  13).  These sera were routinely analyzed for 
Abbreviations used in this  paper: CFA, complete Freund's adjuvant; DNP, 2,4-dinitrophenyl; 
FCS, fetal  calf  serum; Hy, hemocyanin; MEM,  minimal essential  medium; NMS, normal mouse 
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specificity  and cytotoxic activity by a complement-mediated microcytotoxicity assay employing 
trypan blue dye exclusion (12). Using the appropriate target strain and antiserum combinations, 
these anti-Ia antisera cytolyze 50-60% of splenic lymphocytes with a cytotexic titer >1/1,000. Most 
of the experiments utilized BALB.K spleen cells and A.TH anti-A.TL antisera or A.TH normal 
mouse serum (NMS).  (B10 × HTI)FI anti-B10.A(5R)  was the kind gift of Dr. Donal Murphy and 
had cytotoxic antibody activity against products of the IC  ~ subregion, which shares cross-reacting 
Ia specificities  with 1C  ~ (32). 
Fresh frozen rabbit serum was used as the complement (C') source. Rabbit serum was adsorbed 
with agarose, and the complement activity and nonspecific toxicity screened before use by methods 
described previously (12, 13). 
Pretreatment of Donor Spleen Cells.  Spleens from adult, nonimmune, or DNP-Hy immunized 
mice were exhaustively flushed with Dulbecco's phosphate-buffered saline  (PBS,  Grand Island 
Biological  Co., Grand Island, N.  Y.)  supplemented with 5% heat-inactivated fetal calf serum 
(FCS). Cell viability, measured by trypan blue dye exclusion, was usually >90%. 
100 ×  106 spleen cells were pelleted in plastic Falcon tubes (Falcon Plastics, Oxnard, Calif.), 
resuspended in 1 ml of NMS or anti-Ia antiserum diluted 1/5 in PBS-FCS, and incubated for 25 rain 
at 4°C. After washing in PBS-FCS, the pretreated spleen cells were then incubated in 3-4 ml of 
adsorbed rabbit  complement, diluted  1/8-1/12 in Dulbecco's minimal  essential  medium  (MEM) 
(GIBCO) for 45 rain in a 37~C, 95% air-5% COs aerated incubator. After C' incubation, the cell 
suspensions were immediately placed on ice, and the percent cytotoxicity was measured by dye 
exclusion.  The cells were washed three times in MEM and adjusted to a cell concentration of 1-2 × 
10  ~ viable  cells/ml.  Lethally  irradiated,  carrier-primed  recipients  received  1-2  ×  10  ~ viable, 
pretreated cells intravenously (i.v.). The number of total donor cells injected was calculated on the 
basis of the final cell count measured by dye exclusion before cell injection. 
Fragment Cell Culture and Radioimmunoassay.  The frequency of hapten-specific clonal pre- 
cursor cells was measured by an in vitro splenic focus technique for B-cell cloning. The methodol- 
ogy of this technique and the detection of positive (anti-hapten antibody producing) fragment 
cultures have been described previously (30). 14-16 h after cell transfer, recipient spleens were 
sliced into l-ram cubes, placed in vitro in organ fragment culture, and stimulated for 3 days with 1 
× 10  -8 M DNP-Hy. Culture fluids were changed and collected at 2- to 3-day intervals thereafter. 
The production of anti-DNP  monofocal antibody by the  splenic  foci was determined  by a 
sensitive, relatively affinity-independent radioimmunoassay using a DNP-lysine-conjugated-bro- 
moacetyl cellulose immunoadsorbent and l~SI-labeled  purified rabbit anti-mouse Fab antibody (30, 
31). The heavy chain class of anti-DNP monofocal antibody produced by each clone was also 
determined by the radioimmunoassay using iodinated, purified goat antibodies against either the 
mouse ~- or ~l-heavy chain class (30, 33). 
Results 
The frequency of DNP-specific precursor cells  in the  spleens  of nonimmune 
and  DNP-Hy  immunized  adult BALB.K  mice was  quantitated  after pretreat- 
ment either with A.TH N'MS or with A.TH anti-A.TL antiserum  (anti-Ia  k) and 
complement.  Limiting  numbers  (1-2  ×  106  viable  cells  per  recipient)  of pre- 
treated spleen cells were injected into lethally irradiated,  carrier  (Hy)-primed, 
syngeneic recipients.  No primary foci were detected after transfer of either NMS 
or  anti-Ia  k  and  complement-pretreated  cells  into  lethally  irradiated,  normal 
syngeneic  recipients.  This  is  consistent  with  previous  findings  that  carrier- 
primed  recipients  are  necessary  for the  induction  of primary  B-cell  clones by 
DNP-Hy  (30, 34). 
After  pretreatment  with  NMS  and  complement,  the  average  frequency  of 
BALB.K primary precursor cells specific for DNP ranged from 6-10 foci per 10  ~ 
total injected cells, with a mean frequency of 7.64 foci per 10  ~ cells (Table I). This 
frequency is similar to that obtained with untreated,  nonimmune  spleen  cells 
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complement, however, the mean precursor cell frequency was lowered to 0.94 
foci per 106 total injected cells, a reduction of 88%. While the majority of DNP- 
specific primary B cells are thus Ia positive, a small amount of primary precur- 
sor cell activity does remain after negative selection. Pretreatment of nonim- 
mune spleen cells with the reciprocal antiserum, A.TL anti-A.TH  (anti-IaS), 
does not reduce the precursor cell frequency (Table II); this is expected, since the 
H-2 k  and  H-2 s  haplotypes do  not share  cross-reacting Ia  specificities when 
antisera produced by reciprocal immunization are used (2,  14). Table II also 
demonstrates that this negative selection procedure is complement dependent. 
The results of three experiments in which spleen cells from BALB.K mice 
previously immunized to  DNP-Hy  in  CFA  were  treated  with  anti-Ia  k  and 
complement, and subsequently analyzed for precursor cell activity,  are pre- 
sented in Table III. The mean frequency of NMS-treated DNP-specific secondary 
precursor cells is 13.46 foci per 106 injected cells. This frequency was reduced to 
0.59 per 106 cells after negative selection, a reduction of 96%. Hence, secondary 
precursor cells can be almost totally eliminated. 
The monofocal anti-DNP antibodies produced by the primary and secondary 
clones presented in Tables I and HI were analyzed for their isotype (heavy chain 
class) by radioimmunoassay. The distribution of primary and secondary clones 
producing IgM, IgG~, or beth IgM and IgG~ anti-DNP antibody is shown in Table 
IV. After pretreatment of the donor spleen cells with NMS and complement, an 
average of 72% of the clones produced only IgG1 antibody; 14% produced only 
IgM antibody;  and  14%  produced both IgM and IgG1 antibody  (double pro- 
ducers). Less than 10% of the clones dete~ed by 125I-anti-Fab antibody produced 
anti-DNP antibody which was neither of the /~- or y~-heavy chain class. This 
isotype distribution of anti-DNP monofocal antibodies produced by BALB.K 
primary clones is similar to that  observed for BALB/c clones (33). Primary 
clones derived from spleen cells pretreated with anti-Ia  k and complement gave 
an isotype distribution markedly altered from that of the NMS and complement 
control group. An average of 78% of the clones generated from the remaining 
primary B  cells produced solely IgM anti-DNP antibody; 18% produced IgG1 
antibody; and 4% produced both IgM and IgG1 antibody. The secondary monofo- 
cal  antibody isotype distribution is distinct from that of primary monofocal 
antibodies: an average of 2% of secondary clones produced solely IgM anti-DNP 
antibody; the other clones produced either IgG1 or both IgM and IgG~ antibody. 
After  negative  selection,  however,  the  majority  of clones derived from  the 
secondary spleen cell population produced solely IgM antibody. 
The selective survival of purcursor cells which give rise to solely IgM anti- 
body-producing clones is further illustrated in  Fig.  1 and 2.  From the data 
presented in Tables I, HI, and IV, the frequency per 106 total injected cells of 
primary and secondary precursor cells giving rise to clones producing antibody 
of the/~, ~1, or beth/~ and Y~ heavy chain class was calculated. It is apparent 
that the reduction in the total primary precursor cell frequency is correlated 
with the marked reduction (>95%) in the mean frequency of primary B  cells 
giving rise to IgG~ antibody-producing clones (Fig. 1). In contrast, on a total cell 
basis, the mean frequency of primary precursor cells which give rise to solely 
IgM antibody-producing clones is only slightly lowered (20-30%). The precursor 418  ZXPmZSSION OF  Ia  ANTIGENS  ON  HAPTEN-SPECIFIC  B  CELLS 
TABLZ  I 
Effect  of  Anti-la  k  and Complement on the  Frequency of  DNP-Specific  Primary Precursor  Cells 
Pretreatment*  No. viable  No. total  do-  No. clones  Total  no.  No. total  do- Average fro- Reduction in 
Exp.  donor cells/  nor cells/re- detected/re-  clones  nor cells  in-  quency/10  s  clonal  fre- 
Serum  Kill  recipients  cipient  cipient  jected  total  cells§  quency 
%  % 
1  NMS/C'  15  1.0 x 10"  1.1 × 10"  13,9  22  2.2 x 10"  10.0  92 
lak/C  '  62  1.0 × 10"  2.8 × 106  2,1,4  7  8.4 × 10"  0.83 
2  NMS/C'  26  1.0 × 10"  1.2 × 10"  7,8,6  21  3.6 × 10"  5.83  92 
Iak/C  '  63  1.0 x i0  ~  2.9 × 10"  1,0,3  4  8.7 x 10"  0.46 
3  NMS/C'  ii  1.8  x  i0"  1.9  x  10"  19,11  30  3.8  x  10"  7.89  78 
laXlC  '  62  2.1 x i0"  3.8 × i0  ~  7,6,7  20  11.4 x 10"  1.75 
4  NMS/C'  9  2.0 x  10"  2.2  ×  10"  15  15  2.2  ×  106  6.82  90 
lak/C '  67  2,0  ×  10"  3.3  x  10"  3,3,1  7  9.9  x  10"  0.71 
Average of four exp:{I 
NMS/C'  7.64  (0.45)  I  88 
laX/C '  0.94  (0,14)  l 
* BALB.K donor spleen cells were incubated with I ml of 1/5 A.TH NMS or A.TH anti-A.TL antiserum per I00 x  10" cells at 4°C for 25 rain, 
washed, and then incubated with rabbit complement (~/, -  lh2) at 37~C for 45 rain. Percent cytotoxicity was measured by trypan blue dye 
exclusion immediately thereafter. 
S Spleen cells washed three times aRer complement incubation; cell viability measured by dye exclusion. 
§ Average DNP-specific clonal precursor cell  frequency calculated by dividing total number of detected clones by total number of cells 
injected. 
[I Mean frequency per 10  ~ total cells; numbers in parentheses indicate standard error of the mean. 
TABLZ II 
Specificity of Precursor Cell Frequency Reduction 
Serum  pretreat-  Addition  of C' 
ment* 
Mean  precursor  cell  fre- 
quency  per  106 total  cells* 
NMS  +  6.97  (0.92) 
Ia  s  +  7.87  (1,74) 
Ia  k  -  4.69  (1.44) 
Ia  k  +  0.80  (0.12) 
* BALB.K  primary  spleen cells were incubated with A.TH  NMS,  A.TH 
anti-A.TL  antiserum  (la~), or A.TL  anti-A.TH  antiserum  (la  s) for 25 
rain at 4°C,  washed,  and  then  incubated  for 45 min  at 37°C  in the 
presence  or absence  of rabbit complement  (C'). 
* Mean  precursor  cell frequency  of three experiments;  numbers  in pa- 
rentheses  are the standard  error of the mean. 
cell contribution to the total primary IgM response is reduced by pretreatment 
with anti-Ia  k and complement, since the contribution to total IgM antibody by 
clones producing both IgM and IgG1 antibody has been depleted (>90%) as well. 
Pretreatment  of secondary spleen cells reduced the frequency of secondary B 
cells giving rise to IgG1 antibody-producing clones by 95% and the frequency of 
secondary B cells giving rise to both IgG1 and IgM antibody-producing clones by 
100% (Fig. 2). The low frequency of precursor cells in the secondary spleen cell 
population giving rise to only IgM antibody-producing clones was not affected. 
Two "restricted"  Ia antisera were also analyzed for their ability to reduce the 
DNP-specific primary precursor cell response. Spleen cells from BALB.K mice 
were treated with an (A.TH × B10.HTT)F~ anti-A.TL serum (023) or with a (B10 JOAN  PRESS,  NORMAN  KLINMAN,  AND  HUGH  McDEVITT  419 
TAaL~. HI 
Effect of Anti-la  k and Complement  on the Frequency of DNP-Specific Secondary Precursor 
Pretreatment*  I  No. viable 
Exp.  ,.  donor cells/ 
Serum  Kill  recipient~ 
% 
NMS/C'  14  1.0  ×  10  ~ 
lak/C '  64  1.0  x  10  ~ 
NMS/C'  14  1.0  x  10  ~ 
Iak/C '  59  1.0  x  10  ~ 
NMS/C'  15  1.0  x  10  ~ 
Iak/C '  54  1.0  x  10  ~ 
Cells 
No. total do-  No. clones 
nor rolls]re-  detected/re- 
cipient  cipient 
1.3  ×  10  ~  16,19,13 
2.1  x  10  ~  4,1,2 
1.3  ×  10  ~  12,18,15 
2.2  ×  10"  2,1,1,0 
1.2  ×  10  ~  22,16,14 
1.5  ×  10  ~  0,0,0,0.5 
Total no. 
clones 
48 
7 
45 
4 
52 
0.5 
No.  total do- 
nor cells in- 
jncted 
3.9  x  10  a 
6.3  x  10  ~ 
3.9  x  10  ~ 
6.6  x  10  ~ 
3.6  x  10  ~ 
6.0  x  10  ~ 
Average fro-  Reduction  in 
quoncy/108  clonal  fro- 
total cells§  quency 
% 
12.31  91 
1.11 
13.64  96 
0.60 
14.44  99 
0.08 
Average of three e~ 
NMS/C'  13.46 (0.62)  [  96 
lak/C '  0.59 (0.29)  | 
* Spleen cells from BALB.K mire primed with 0.1 mg DNP-Hy  in CFA 6-8 wk previously  were incubated with 1 ml of 1/5 A.TH N'MS or 
A.TH anti-A.TL  antiserum  (la  k) per 100 x  10  ~ cells at 4°C for 25 rain, washed, and then incubated with rabbit complement  (1/8 -  l/lZ) at 
37~C for 45 rain.  Percent cytotoxicity  was measured  by trypan blue dye exclusion  immediately  theresl~er. 
Spleen cells washed three times after complement incubation; cell viability was measured by dye exclusion.  Cells transferred i.v. into Hy 
carrier-primed,  irradiated  BALB.K mice. 
§ Average DNP-specific  clonal precursor cell frequency calculated  by dividing total  no, of detected clones by total no. of cells injected. 
II Mean frequency per 10  ~ total cells; numbers in parentheses  indicate standard  error of the mean. 
×  HTI)F1 anti-B10.A(5R)  serum  (As120)  and complement.  The former antise- 
rum has antibody activity against gene products of the I-Ak and I-B k subregions, 
while the latter antiserum reacts with gene products of the I-C  e subregion and 
cross-reacts with products of the I-C  ~ subregion  (32). Asl20 may also contain 
antibodies  reactive  with gene  products  of the S d subregion  (D.  B.  Murphy, 
personal  communication).  Treatment with either antiserum  significantly  re- 
duced primary precursor cell activity (Table V). Similar results were obtained 
when an A.TH anti-A.TL serum was used with BALB.B (H-2  b) or BALB/c (H- 
24) spleen cells (data not shown), an expected finding since the H-2 b and H-2 d 
haplotypes share some cress-reacting Ia specificities with the H-2 k haplotype (2, 
14, 29). 
Discussion 
The studies presented here were conducted to determine whether Ia antigens 
are expressed on DNP-specific B cells and whether the expression of Ia determi- 
nants can be used to delineate B-cell subpopulations in the spleens of nonim- 
mune and previously immunized mice. To measure the relevance of Ia expres- 
sion  to specific precursor cell  stimulation  on a  cell  to cell  basis,  and  under 
conditions of T-cell excess, the experimental approach employed negative selec- 
tion with specific anti-Ia serum and complement and an in vitro splenic focus 
technique (30) for B-cell cloning. The splenic focus technique allows the enumer- 
ation  of clonal  precursor  cells  in  the population  with  and  without negative 
selection and permits an analysis of effects of such selection at the level of the 
individual B cell and its clonal progeny. 
It has been demonstrated using this splenic focus technique that the limiting 
cell for focus formation is the B cell, and that the monofocal antibody produced is 
derived from the clonal progeny of a single stimulated precursor cell  (30,  34). 420  EXPRESSION  OF  Ia  ANTIGENS  ON  HAPTEN-SPECIFIC  B  CELLS 
TABLE I~ 
Effect of Anti-Ia  k and Complement  on the Isotype of Monofocal Antibody Produced Per 
Clone 
Pretreat- 
Exp.*  ment 
No. clones  producing monofocal an- 
tibody of  isotype~ 
Clones producing monofocal 
antibody of  isotype 
71  P  + Yl  (Fab)§  ~  71  ft +  71 
% 
Primary precursor cell 
1  NMS/C'  3  18  1  -  13.6  81.8  4.6 
Iak/C  '  6  1  0  --  85.7  14.3  0 
2  NMS/C'  4  15  2  -  19.0  71.4  9.6 
Iak/C '  4  0  0  -  100  0  0 
3  NMS/C'  3  20  7  -  10.0  66.7  23.3 
Iak/C  '  14  3  3  -  70.0  15.0  15.0 
4  NMS/C'  2  10  3  -  13.3  66.7  20.0 
Iak/C '  4  3  0  -  57.1  42.9  0 
Secondary precursor cell 
1  NMS/C'  0  23  25  -  0  47.9  52.1 
Iak/C '  4  3  0  -  57.1  42.9  0 
2  NMS/C'  0  9  36  -  0  20.0  80.0 
Iak/C  '  2  2  0  -  50.0  50.0  0 
3  NMS/C'  3  26  20  3  5.8  50.0  38.5 
Iak/C '  0.5  0  0  0  100  0  0 
* See Tables I and III for details. 
DNP-specific clones from Tables I and III analyzed for heavy chain class by radioimmunoaseay. 
§ Fab refers to clones detected by 125I rabbit anti-mouse Fab which are not detected by either 
iodinated anti-~ or anti-T1 antibody; in general, such clones represent <10% of the total clones. 
The majority of splenic foci produce antibody that  appears homogeneous  by the 
criteria of heavy  and light chain recombination  analysis, equilibrium  dialysis, 
idiotypic analysis, and isoelectric focusing (30, 34, 35). The only exception to the 
evidence  for  the  homogeneity  of the  monofocal  antibody  produced  by  these 
clones  has  been  the  demonstration  that  a  significantly greater  than  random 
frequency of individual clones produce monospecific anti-DNP  antibody in beth 
the ft- and 7rheavy  chain classes (33). The occurrence of double producers and 
the implication that the clonal progeny of a  single stimulated precursor cell may 
produce  antibody  in  more  than  one  heavy  chain  class  specific  for  a  single 
determinant  has recently been confirmed by the studies of Gearhart  et al.  (35), 
who demonstrated  that monospecific, antiphosphorylcholine antibodies from the 
same  clone  were  of  more  than  one  heavy  chain  class,  yet  share  the  same 
specificity region by idiotypic analysis. 
Expression of la Antigens on B-Cell Subpopulations.  Inasmuch  as the sec- 
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almost  every  secondary  B  cell  must be Ia positive.  In contrast,  a  small  but 
discernible amount of primary B-cell  activity is retained ai~r negative selec- 
tion, suggesting that some primary B cells are Ia negative. The terminology Ia 
negative includes those B cells which may possess Ia molecules on their surface, 
but in quantity or density too low to permit cytolysis by antibody and comple- 
ment, or detection by immunofluorescent analysis on the fluorescence-activated 
cell sorter (36). The reduction in the primary B-cell frequency is due primarily to 
the elimination of B cells which would have given rise to clones producing IgG1 
anti-DNP  antibody.  The  frequency of precursor  cells  generating  solely  IgM- 
producing progeny is only slightly affected. However, the overall primary IgM 
antibody response is affected since the precursor cells which yield clones produc- 
ing both IgG and IgM antibody are Ia positive and are eliminated as well. It is 
not  clear  whether  the  low frequency  of Ia-negative  precursor  cells  and  the 
quantity of IgM antibody elaborated by their clonal progeny would be sufficient 
to permit detection by either in vivo or other in vitro techniques.  It has been 
possible to  demonstrate  in an  in vivo  cell  transfer  system  employing excess 
helper T cells that the primary IgG antibody response to ferritin is significantly 
diminished when the nonimmune donor spleen cells are negatively selected with 422  EXPRESSION  OF  Ia  ANTIGENS  ON  HAPTEN-SPECIFIC  B  CELLS 
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Ia antiserum and complement before cell transfer (J. Press, S. Strober, and H. 
McDevitt.  Manuscript  in  preparation).  The  negative  selection  procedure  is 
complement dependent and apparently Ia determinant specific, since restricted 
antisera directed against antigens specified by the I-A and I-B, or I-C subregions 
are also effective in reducing the primary B-cell response. JOAN  PRESS,  NORMAN  KLINMAN,  AND  HUGH  McDEVITT 
TABLE  V 
Expression of l Subregion Defined Ia Specificities on Primary B Cells 
423 
Exp. 
Serum*  Frequency per 106 total cells  Total  Potential I 
pretreat-  Kill  Isotype distribution  reduc-  subregions 
ment  tion  detected  y~  p  +  y~  Totals 
2§ 
%  % 
NMS  11  0.21  5.83  0.42  6.46 
023  57  0.19  1.86  0.09  2.13  67  I-A, I-B 
014  13  2.5  4.2  1.8  9.6 
023  50  2.1  0.77  0.38  3.5  64  I-A, I-B 
Asl20  54  1.5  0.19  0  2.2  77  I-C 
* Antisera used: NMS, A.TH normal mouse serum; 014, A.TL anti-A.TH (anti-I-A', I-B', I-C', S', 
G'); 023, (A.TH × B10.HTT)FI anti-A.TL (anti-l-A  k, I-Bk); Asl20, (B10 × HTI)F1 anti-B10.A(5R) 
(anti.I-C a, Sa). 
S Total clonal precursor cell frequency per 106 injected cells, including clones detected with ~25I- 
anti-Fab, but not l~I-anti-~ or anti~  antibody. 
§ In this experiment, 014 is used as the control serum vs. H-2 k. 
The expression of Ia antigens thus appears to define two subsets of primary B 
cells. The majority of primary B cells are Ia positive and have the potential to 
generate IgG-producing progeny. There is also a small subpepulation of B cells 
which is by definition Ia negative. These B cells generate only IgMoproducing 
clones  under  the  conditions employed in  these  studies.  Ia-positive  and  Ia- 
negative B  cells can therefore be demarcated by their clonal phenotype. Two 
other pieces of evidence indicate that Ia-negative B  cells exist as a  discrete 
subset: (a) when nonimmune spleen cells are separated by immunofluorescence 
on the cell sorter, significant precursor cell activity can be detected in the Ia- 
negative cell population (J.  Press, unpublished observations); (b) analysis by 
size fractionation on 1 g  velocity sedimentation gradients indicates that the Ia- 
negative B cells which give rise to only IgM-producing  clones are found predomi- 
nantly in the large cell fractions, whereas both the large and small cell fractions 
contain Ia-positive primary B cells (37). 
The interrelationship of the Ia-positive and Ia-negative B-cell subsets is not 
clear. A continuum may exist within the nonimmune adult spleen, where Ia- 
negative (and possibly Ig negative) B cells differentiate into Ia-pesitive cells. In 
this single pathway model, the B cell would acquire the capacity to switch to IgG 
production concomitant with  the expression of Ia,  and the expression of Ia 
molecules could be used as a marker to follow B-cell maturation. Alternatively, 
the Ia-positive and negative B-cell subsets may constitute separate,  parallel 
lineages. The Ia-negative B-cell subset would exist in low frequency in the adult 
spleen and would not diferentiate into Ia-positive cells. Preliminary findings 
indicate that the IgM-producing clonal progeny of Ia-negative B  cells do not 
express Ia antigens during the in vitro culture period (J. Press and N. Klinman, 
unpublished observations).  It  is  not  clear  whether Ia-negative  B  cells  are 
capable of making IgG antibody but do not due to the lack of Ia determinant 
expression, or whether such cells are intrinsically capable of  producing only IgM 424  EXPRESSION  OF  Ia  ANTIGENS  ON  HAPTEN-SPECIFIC  B  CELLS 
antibody upon stimulation. It will be of interest to determine whether the Ia- 
positive and Ia-negative B-cell subsets share the same repertoire of antibody 
clonotypes and express the same requirements for stimulation, particularly with 
regard to T-cell dependent versus T-cell independent antigens. 
Inasmuch as the expression of Ia antigens on the B cell correlates with the 
ability of that cell to give rise to IgG production, Ia molecules may have a role in 
the specific induction of the B-cell switch mechanism from IgM to IgG produc- 
tion. Indirect support for this speculation comes from recent findings of Pierce 
and Klinman (11) that 60-70% of primary B cells can be stimulated in alloge- 
neic, carrier-primed recipients. This stimulation does not occur if the allogeneic 
recipient is not carrier primed. When the donor and recipient haplotype combi- 
nations were selected such that there was genetic nonidentity only in the I-A 
and I-B subregions, then antigen-specific stimulation yielded clones producing 
solely IgM anti-DNP antibody. In contrast, if there were background differences 
only, or differences in the H-2D end, then IgG antibody-producing clones were 
obtained (11). These findings have been confirmed using several congenic and 
recombinant strain combinations, but there may be preferred H-2  haplotype 
combinations for optimal stimulation (J. Press and N. Klinman, unpublished 
observations). 
Thus, gene products affecting the ability of B-cell-T-cell interactions to lead to 
IgG production map in the I region (7-11). However, Ia recognitive interactions 
between B cells and T cells do not appear obligatory for B-cell triggering per se, 
since Ia-negative cells can be specifically stimulated to IgM antibody produc- 
tion. These data suggest that the Ia-positive primary B cell can give rise either 
to IgM or to IgG production, depending on whether there is/-region identity 
between the B cell and T cell. This is compatible with the hypothesis that Ia 
antigens are involved in the B-cell induction to IgG production. The requisites 
for/-region identity between B cells and T cells for IgG production may be more 
stringent for primary B cells than for secondary B cells (38; J. Press, unpub- 
lished observations). In situations where IgG antibody is elicited in histoincom- 
patible T-cell-B-cell interactions, e.g.  tetraparental mice (5) or bone marrow 
chimeras (39), this could be due either to tolerance of alloreactive T cells or to 
the learned recognition of both parental haplotype cell surface/-region antigens 
as a consequence of in situ immunization. 
It is clear that the expression of Ia molecules on B cells can be used to classify 
at least two DNP-specific primary B-cell subpopulations in the spleens of adult 
mice. At issue is whether Ia expression is a  B-ceU differentiation event in a 
common lineage pathway and whether Ia antigens per se have any functional 
role in the IgM to IgG switch mechanism. The cellular expression of Ia mole- 
cules may constitute an inherent molecular mechanism for the regulation of B- 
cell stimulation. This regulatory role of Ia determinants could be quite distinct 
from the mechanism of action and antigen specificity of Ir genes. Experiments 
are in progress to resolve these issues. 
Summary 
The nonimmune adult spleen contains at least two B-cell subpopulations. The 
majority of primary B cells express cell surface Ia determinants and have the JOAN  PRESS,  NORMAN  KLINMAN,  AND  HUGH  McDEVITT  425 
capacity to give rise to IgG antibody-producing clones afLer T-cell dependent 
antigenic stimulation. There is also a  small subpepulation of primary B cells 
which are, by definition, Ia negative, since their activity is not eliminated by 
negative selection with anti-Ia serum and complement. The Ia-negative B cells 
give rise to clones that produce only IgM antibody. These B-cell subsets may 
form a  continuum in B-cell maturation, or they may exist as discrete B-cell 
lineages. Since the cellular expression of Ia antigens appears to correlate with 
the ability of the B cell to generate IgG-producing clones, it is speculated that Ia 
molecules may have a role in the IgM to IgG B-cell switch mechanism. 
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